← Compare landing
Pluri vs SCTbio
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Pluri | SCTbio |
|---|---|---|
| Summary | Full-service CDMO specializing in cell therapy manufacturing with GMP facilities, proprietary packed-bed expansion technology, and regulatory approvals from FDA, EMA, PMDA, and other key agencies for clinical-stage production. | SCTbio is a European cell and gene therapy CDMO offering cGMP manufacturing, lentiviral and gammaretroviral vector production, analytical development, and QP batch release. Its facilities include 420 m² of Class A/B/C GMP cleanrooms, and it reports more than 2,000 GMP batches manufactured. |
| Services |
|
|
| Modalities |
|
|
| Development capabilities |
|
|
| Manufacturing capabilities |
|
|
| Locations |
|
|
| Certifications |
| Data not yet provided. |
Find similar companies
Markdown mirror: /compare/pluri-biotech/sctbio.md